Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Med Clin North Am ; 105(2): 263-272, 2021 Mar.
Article in English | MEDLINE | ID: mdl-33589101

ABSTRACT

Although statins are generally safe and well tolerated, some patients experience muscle complaints that can be attributed to their use. Those with muscle discomfort but no demonstrable muscle weakness or creatine kinase (CK) elevations may have statin-associated muscle symptoms. Individuals with elevated CK levels, with or without muscle discomfort or weakness, may have statin-associated myotoxicity. Rare patients have statin-associated autoimmune myopathy, a disease characterized by proximal muscle weakness, elevated CK levels, and autoantibodies recognizing hydroxy-methyl-glutaryl coenzyme A reductase. In this review, the author provides the clinician with a practical approach to diagnosing and managing patients with each of these statin side effects.


Subject(s)
Hydroxymethylglutaryl-CoA Reductase Inhibitors , Hyperlipidemias/drug therapy , Myotoxicity , Autoimmunity/drug effects , Humans , Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects , Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use , Hyperlipidemias/blood , Lipoproteins, LDL/analysis , Myotoxicity/etiology , Myotoxicity/immunology , Myotoxicity/physiopathology , Myotoxicity/therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...